Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple-to-use, rapid, cost effective, portable system.
Need to source reagents for assay development? We have an extensive list of assay reagents for tropical diseases in… https://t.co/1dnnBcsfjn
22 March 2018
© Abingdon Health 2018